Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Published:2021-05 Issue:5 Volume:22 Page:702-715
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Conroy Thierry,Bosset Jean-François,Etienne Pierre-Luc,Rio Emmanuel,François Éric,Mesgouez-Nebout Nathalie,Vendrely Véronique,Artignan Xavier,Bouché Olivier,Gargot Dany,Boige Valérie,Bonichon-Lamichhane Nathalie,Louvet Christophe,Morand Clotilde,de la Fouchardière Christelle,Lamfichekh Najib,Juzyna Béata,Jouffroy-Zeller Claire,Rullier Eric,Marchal Frédéric,Gourgou Sophie,Castan Florence,Borg Christophe,Borg Christophe,Etienne Pierre-Luc,Rio Emmanuel,Mesgouez-Nebout Nathalie,François Éric,Vendrely Véronique,Conroy Thierry,Artignan Xavier,Bouché Olivier,Gargot Dany,Boige Valérie,Bonichon-Lamichhane Nathalie,Louvet Christophe,Morand Clotilde,de la Fouchardière Christelle,Ronchin Philippe,Seitz Jean-François,Corbinais Stéphane,Maillard Emmanuel,Noirclerc Monique,El Hajbi Farid,Ronchin Philippe,Villing Anne-Laure,Bécouarn Yves,Foong Fat Lam Kam Sang Lam,Artru Pascal,Bachet Jean-Baptiste,Hocine Fayçal,Ligeza-Poisson Catherine,Vautravers Claire,Ben Abdelghani Meher,Aparicio Thomas,Desot Elise,Marquis Isabelle

Funder

French National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Chemotherapy with preoperative radiotherapy in rectal cancer;Bosset;N Engl J Med,2006

2. Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer;Azria;Ann Oncol,2017

3. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012

4. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial;van Gijn;Lancet Oncol,2011

5. Association of plane of total mesorectal excision with prognosis of rectal cancer: secondary analysis of the CAO/ARO/AIO-04 phase 3 randomized clinical trial;Kitz;JAMA Surg,2018

Cited by 495 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer;Surgery Open Science;2024-03

2. VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancer;ESMO Gastrointestinal Oncology;2024-03

3. From Clinical Trials to Practice: Anticipating and Overcoming Challenges in Implementing Watch-and-Wait for Rectal Cancer;Journal of Clinical Oncology;2024-02-05

4. Comparison of prognosis for locally advanced T4b rectal cancer with different pelvic compartment involvement treated using neoadjuvant chemoradiotherapy and implications for refinement of the current TNM staging system;2024-02-02

5. UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?;Critical Reviews in Oncology/Hematology;2024-02